Sign In

Alexander Goemans

CFO @ Xeltis

Alexander Goemans is the Chief Financial Officer (CFO) of Xeltis, a position he has held since November 2021. He brings extensive experience in financial management, strategy consulting, and investment to his role. Before joining Xeltis, Goemans served as CFO at miDiagnostics, a molecular diagnostics company, where he played a key role in financial operations and strategic initiatives.

His career began as a strategy consultant at McKinsey & Company, focusing on mergers and acquisitions (M&A) and private equity across various industries. Throughout his career, he has successfully raised over €300 million in equity and debt for private companies, demonstrating his expertise in financial structuring and fundraising.13

Goemans holds a Master of Science in Business Engineering from KULeuven and a Master of Science in Finance from the London School of Economics. His educational background complements his professional experience, making him well-suited to lead financial strategies at Xeltis as the company advances its innovative medical technologies.123

Highlights

Mar 4 · linkedin

Dear All,

I need your help.

At Xeltis, we use groundbreaking science to improve the lives of dialysis patients. We see all complications they experience, and the struggles they go through regularly. We are reminded daily how brave our patients are, and therefore would like to help improve their quality of life as much as possible. This is why we are participating as a team to collect money for the Kidney Foundation.

Here’s where I need your help. All my colleagues we’ll be running, cycling or walking a selected length to raise money and I’m planning to run 5km. How hard that 5km will be is up to you, for every €100 raised I'll run with an added 2kg in weights*. So helping kidney patients or seeing me suffer, whatever your motivation, every € is appreciated!

Thanks, Alex

  • 10kg max ;-)
Apr 30 · linkedin

Great article by Michael Sephiha in De Tijd this morning covering our EUR 58 million financing to accelerate the launch of our ultra-fast #COVID19 PCR test. miDiagnostics is looking to reduce the wait time for COVID-19 PCR tests to less than 15 minutes, much quicker than the ~6 hours that central lab results can take.   The new funding has been raised by existing investors contributing EUR 38 million, with an additional EUR 20 million available from the European Investment Bank. Following this news, miDiagnostics remains fully anchored in Flanders. “Thanks to the support of our existing Flemish shareholders, we will now be able to evolve from a very promising research and development company to a fully integrated commercial diagnostics company, offering immediate solutions that demand answers in this COVID-19 crisis”, independent director Peter Verhaeghe told De Tijd.   We’re also announcing a strengthening of our management team today, with Katleen Verleysen appointed as CEO and Hans Vanderwegen appointed as COO.   Read the full article here: https://lnkd.in/gvXqPCy   #COVID19 #PCR #Diagnostics #Fundraise

Related Questions

What are Alexander Goemans' key achievements at Xeltis?
How did Alexander Goemans' role at miDiagnostics prepare him for his position at Xeltis?
What specific strategies has Alexander Goemans implemented at Xeltis?
How has Alexander Goemans' experience at McKinsey & Co. influenced his approach at Xeltis?
What are Alexander Goemans' future plans for Xeltis?
Alexander Goemans
Alexander Goemans, photo 1
Alexander Goemans, photo 2
Add to my network

Location

Antwerp Metropolitan Area